Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters
- PMID: 1694931
Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters
Abstract
In a recent study in which metabolic characteristics of newly detected obese and nonobese hypertensive subjects were compared with those of normotensive subjects, insulin sensitivity was decreased, fasting insulin values and insulin values after an intravenous glucose tolerance test (IVGTT) were increased, and fasting and IVGTT glucose values were increased in both hypertensive groups. Furthermore, adverse alterations in lipid profile variables were found in the hypertensive groups when compared with the normotensive group. The effects of various antihypertensive agents on these metabolic variables have been assessed in prospective trials. Treatment with the beta 1-selective blocking agents metoprolol and atenolol was associated with decreased insulin sensitivity and increased fasting values of insulin and glucose. There were also indications of a suppressive effect on insulin secretion during IVGTT, as well as an increase in serum triglycerides and a decrease in serum high-density lipoprotein cholesterol. Hydrochlorothiazide treatment was associated with a decrease in insulin sensitivity and an increase in blood glucose concentrations. In addition, hydrochlorothiazide increased total cholesterol, particularly the low-density lipoprotein fraction. The calcium channel blocker diltiazem did not appear to produce any negative metabolic effects. Treatment with the angiotensin converting enzyme inhibitor captopril resulted in increased insulin sensitivity with no adverse effects on lipids. All of the agents reduced blood pressure to a similar degree. These findings, and those of other studies, suggest that captopril and diltiazem offer advantages over the other agents with regard to effects on risk factors for coronary artery disease other than hypertension. Unlike diltiazem, captopril improves insulin sensitivity and this may prove to be important.
Similar articles
-
Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).J Hypertens. 2003 Aug;21(8):1563-74. doi: 10.1097/01.hjh.0000084723.53355.76. J Hypertens. 2003. PMID: 12872052 Clinical Trial.
-
The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.Int J Clin Pharmacol Ther. 1997 Jun;35(6):231-4. Int J Clin Pharmacol Ther. 1997. PMID: 9208337 Clinical Trial.
-
A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.N Engl J Med. 1989 Sep 28;321(13):868-73. doi: 10.1056/NEJM198909283211305. N Engl J Med. 1989. PMID: 2671740 Clinical Trial.
-
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.Dan Med Bull. 2002 Feb;49(1):43-60. Dan Med Bull. 2002. PMID: 11894723 Review.
-
Insulin resistance and essential hypertension: pathophysiologic and therapeutic implications.J Hypertens Suppl. 1992 Apr;10(2):S9-15. J Hypertens Suppl. 1992. PMID: 1593308 Review.
Cited by
-
ACE-inhibitors and atherosclerosis.Eur J Epidemiol. 1992 May;8 Suppl 1:129-33. doi: 10.1007/BF00145364. Eur J Epidemiol. 1992. PMID: 1324185 Review.
-
Diuretics: a review of the pharmacology and effects on glucose homeostasis.Front Pharmacol. 2025 Mar 28;16:1513125. doi: 10.3389/fphar.2025.1513125. eCollection 2025. Front Pharmacol. 2025. PMID: 40223924 Free PMC article. Review.
-
Treatment of diabetic patients with hypertension.Curr Hypertens Rep. 1999 Jun;1(3):225-31. doi: 10.1007/s11906-999-0025-6. Curr Hypertens Rep. 1999. PMID: 10981070 Review.
-
The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications.Drugs. 2002;62(9):1295-314. doi: 10.2165/00003495-200262090-00002. Drugs. 2002. PMID: 12076180 Review.
-
S15261, a new compound for the treatment of the insulin resistance syndrome.Diabetologia. 1994 Oct;37(10):969-75. doi: 10.1007/BF00400459. Diabetologia. 1994. PMID: 7851691
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical